Neuland Laboratories informs about board meeting

24 Apr 2025 Evaluate

Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Neuland Laboratories has informed that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, May 15, 2025, to Consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2025; and Recommend final dividend, if any, for the financial year 2024-25. In continuation to letter dated March 25, 2025, pursuant to the Company's Insider Trading Code, the trading window for dealing in the equity shares of the Company shall continue to remain closed from April 1, 2025 till 48 hours after the declaration of audited financial results of the Company for the quarter and financial year ended March 31, 2025 and final dividend, if any, for the financial year 2024-25 to the stock exchanges.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

15191.80 95.00 (0.63%)
26-Dec-2025 13:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1714.25
Dr. Reddys Lab 1263.90
Cipla 1503.70
Zydus Lifesciences 910.80
Lupin 2101.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×